These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 18261479)
1. Impact of statin dosing intensity on transaminase and creatine kinase. Gosmanov AR; Lewis JB Am J Med; 2008 Feb; 121(2):e11; author reply e13. PubMed ID: 18261479 [No Abstract] [Full Text] [Related]
2. Impact of statin dosing intensity on transaminase and creatine kinase. Dale KM; White CM; Henyan NN; Kluger J; Coleman CI Am J Med; 2007 Aug; 120(8):706-12. PubMed ID: 17679130 [TBL] [Abstract][Full Text] [Related]
3. Potentials and pitfalls of meta-analysis on statins. Lotrionte M; Agostoni P; Biondi-Zoccai GG Am J Med; 2008 Jan; 121(1):e3; author reply e5. PubMed ID: 18187058 [No Abstract] [Full Text] [Related]
4. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. McKenney JM; Davidson MH; Jacobson TA; Guyton JR; Am J Cardiol; 2006 Apr; 97(8A):89C-94C. PubMed ID: 16581336 [TBL] [Abstract][Full Text] [Related]
5. An assessment of statin safety by muscle experts. Thompson PD; Clarkson PM; Rosenson RS; Am J Cardiol; 2006 Apr; 97(8A):69C-76C. PubMed ID: 16581332 [TBL] [Abstract][Full Text] [Related]
6. Liver transaminase levels alone could not be the optimal method to estimate hepatic safety after statin administration in patients with chronic kidney disease. Molino C; Tiseo R; De Giorgi A; Pala M; Manfredini R Am Heart J; 2011 Jul; 162(1):e15. PubMed ID: 21742076 [No Abstract] [Full Text] [Related]
7. [Creatine kinase increase under simvastatin--therapeutic consequences?]. Rasche-Schürmann CC; Picksak G; Stichtenoth DO Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017 [TBL] [Abstract][Full Text] [Related]
8. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study. Reckless JP; Henry P; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO; Lis K; Brudi P; Allen C Int J Clin Pract; 2008 Apr; 62(4):539-54. PubMed ID: 18266852 [TBL] [Abstract][Full Text] [Related]
10. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study. Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365 [TBL] [Abstract][Full Text] [Related]
11. Creatine kinase: a review of its use in the diagnosis of muscle disease. Gasper MC; Gilchrist JM Med Health R I; 2005 Nov; 88(11):398, 400-4. PubMed ID: 16363394 [No Abstract] [Full Text] [Related]
12. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia? Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957 [TBL] [Abstract][Full Text] [Related]
13. Which statin? Med Lett Drugs Ther; 2008 Apr; 50(1284):29-31. PubMed ID: 18425054 [No Abstract] [Full Text] [Related]
14. Study finds small association between statin use and musculoskeletal conditions. Wise J BMJ; 2013 Jun; 346():f3609. PubMed ID: 23737283 [No Abstract] [Full Text] [Related]
15. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Mannacio VA; Iorio D; De Amicis V; Di Lello F; Musumeci F J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1541-8. PubMed ID: 19114204 [TBL] [Abstract][Full Text] [Related]
16. Improvement of statin-associated myotoxicity by L-carnitine. Arduini A; Peschechera A; Giannessi F; Carminati P J Thromb Haemost; 2004 Dec; 2(12):2270-1. PubMed ID: 15613049 [No Abstract] [Full Text] [Related]
17. Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction. Bauer T; Böhm M; Zahn R; Jünger C; Koeth O; Gitt A; Bestehorn K; Senges J; Zeymer U; J Cardiovasc Pharmacol; 2009 Feb; 53(2):132-6. PubMed ID: 19188836 [TBL] [Abstract][Full Text] [Related]